Injective (INJ) is currently trading at $2.88, reflecting a slight 24-hour decline of -0.58%. The price has fluctuated within a daily range of $2.86 to $2.95, indicating a relatively tight trading band with a low volatility percentage of 0.09%.

The trading volume stands at approximately $42.72 million, which constitutes a significant 14.82% of the market cap, suggesting healthy liquidity. However, the negative 7-day price change of -6.56% and 14-day decline of -5.77% indicate a bearish sentiment over the short term, despite the current price hovering near the hourly moving averages.

The hourly moving averages are all slightly below the current price, with the 8, 13, and 21 SMA showing declines of approximately 1.29%, 1.32%, and 0.71% respectively. The 1-hour RSI at 53 reflects a neutral position, while the 7-day RSI at 48 signals a potential continuation of bearish momentum if it dips below 30.

Injective's all-time high of $52.62 reached in March 2024 remains a distant target, and the recent downtrends suggest that price recovery may face significant resistance. The sustained negative price changes over 30 days further emphasize the ongoing bearish trend and the need for confirmation of bullish reversal signals before any upward movement.

Given the current price action, trading volume, and moving average trends, the outlook for Injective (INJ) remains cautiously negative. Therefore, a "Sell" rating is recommended, as the asset shows signs of continued weakness and lacks immediate catalysts for a price rebound.